Palatin Technologies (PTN) News Today → Dems have chosen Biden replacement? (From Paradigm Press) (Ad) Free PTN Stock Alerts $1.80 -0.07 (-3.74%) (As of 05/31/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestStock AnalysisAnalyst ForecastsChartEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 28, 2024 | americanbankingnews.comPalatin Technologies (NYSEAMERICAN:PTN) Stock Price Crosses Above Two Hundred Day Moving Average of $0.00May 20, 2024 | markets.businessinsider.comPalatin Technologies Upgraded to Buy: What Does It Mean for the Stock?May 16, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Palatin Technologies (PTN) and Prestige Consumer Healthcare (PBH)May 16, 2024 | msn.comPalatin Technologies, Inc. (AMEX:PTN) Q3 2024 Earnings Call TranscriptMay 16, 2024 | finance.yahoo.comQ3 2024 Palatin Technologies Inc Earnings CallMay 16, 2024 | finance.yahoo.comPalatin Technologies Inc (PTN) (Q3 2024) Earnings Call Transcript Highlights: Navigating ...May 15, 2024 | markets.businessinsider.comPalatin Technologies Inc. Q3 Loss DecreasesMay 15, 2024 | prnewswire.comPalatin Reports Third Quarter Fiscal Year 2024 Financial Results and Provides Corporate UpdateMay 9, 2024 | prnewswire.comPalatin to Report Third Quarter Fiscal Year 2024 Results; Teleconference and Webcast to be held on May 15, 2024May 8, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Aquestive Therapeutics (AQST) and Palatin Technologies (PTN)May 3, 2024 | markets.businessinsider.comBuy Rating Endorsed for Palatin Technologies Amidst Promising Obesity Treatment AdvancementsMay 2, 2024 | msn.comPalatin spikes as FDA clears mid-stage trial for weight loss therapyMay 2, 2024 | seekingalpha.comPalatin gets FDA OK to test weight loss therapy with Eli Lilly’s tirzepatideMay 2, 2024 | markets.businessinsider.comPalatin: FDA Clears IND Application For Bremelanotide Phase 2 StudyMay 2, 2024 | prnewswire.comPalatin Announces FDA Clearance of IND Application for the Co-Administration of Bremelanotide with Tirzepatide (GLP-1) for the Treatment of ObesityApril 30, 2024 | prnewswire.comPalatin to Host Virtual KOL Event "Beyond GLPs: The Multiple Roles for Novel Melanocortin Receptor 4 Agonists in Treating Obesity and Weight Loss Maintenance" on May 8, 2024April 12, 2024 | msn.comPalatin Technologies And 2 Other Stocks Under $3 Insiders Are BuyingApril 12, 2024 | insidertrades.comPalatin Technologies, Inc. (NYSEAMERICAN:PTN) Director Purchases $12,720.00 in StockApril 8, 2024 | marketwatch.comPalatin Technologies Shares Rise 27% After Positive Trial Results for PL9643April 8, 2024 | finance.yahoo.comPalatin Technologies Eyes Growing $6B Dry Eye Disease Market With Late-Stage Study DataApril 8, 2024 | msn.comGalectin Therapeutics, Titan Pharmaceuticals, Outset Medical among healthcare moversApril 8, 2024 | msn.comPalatin stock jumps 16% on positive Phase 3 data for eye drugApril 8, 2024 | markets.businessinsider.comPalatin Says Topline Results From The Phase 3 MELODY-1 Study Of PL9643 In Dry Eye Disease PositiveApril 8, 2024 | finance.yahoo.comPalatin Announces Phase 3 PL9643 MELODY-1 Dry Eye Disease (DED) Clinical Data Results Presented at American Society of Cataract and Refractive Surgery (ASCRS) 2024March 17, 2024 | insidertrades.comPalatin Technologies, Inc. (NYSEAMERICAN:PTN) Director Robert K. Deveer, Jr. Sells 11,700 SharesMarch 15, 2024 | finance.yahoo.comPTN Apr 2024 2.500 putMarch 15, 2024 | finance.yahoo.comPTN Apr 2024 7.500 callMarch 14, 2024 | msn.comPalatin files to sell 1.92M shares of common stock for holdersFebruary 29, 2024 | markets.businessinsider.comMaintained Buy Rating on Palatin Technologies Amid Promising Clinical Results and Future ProspectsFebruary 28, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Immunocore Holdings (IMCR), Palatin Technologies (PTN) and G1 Therapeutics (GTHX)February 28, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Palatin Technologies (PTN) and Opko Health (OPK)February 28, 2024 | msn.comPalatin Technologies' Disappointing Data From Dry Eye Disease Study, Stock PlummetsFebruary 28, 2024 | finanznachrichten.dePalatin Technologies, Inc.: Palatin Announces Results of PL9643 MELODY-1 Pivotal Phase 3 Clinical Trial in Patients with Dry Eye Disease (DED)February 28, 2024 | marketwatch.comPalatin Technologies Shares Tumble Premarket on Dry-Eye Study ResultsFebruary 28, 2024 | finance.yahoo.comPalatin Announces Results of PL9643 MELODY-1 Pivotal Phase 3 Clinical Trial in Patients with Dry Eye Disease (DED)February 28, 2024 | prnewswire.comPalatin Announces Results of PL9643 MELODY-1 Pivotal Phase 3 Clinical Trial in Patients with Dry Eye Disease (DED)February 21, 2024 | finance.yahoo.comPalatin Technologies, Inc. (PTN)February 16, 2024 | markets.businessinsider.comBuy Rating Affirmed on Palatin Technologies for Promising Pipeline and Strategic Market PositioningFebruary 16, 2024 | markets.businessinsider.comBuy Rating Affirmed for Palatin Technologies Amid Promising Clinical Trials and Robust Financial PositionFebruary 16, 2024 | finance.yahoo.comPalatin Technologies, Inc. (AMEX:PTN) Q2 2024 Earnings Call TranscriptFebruary 16, 2024 | benzinga.comPalatin Techs Stock (AMEX:PTN), Quotes and News SummaryFebruary 16, 2024 | finance.yahoo.comQ2 2024 Palatin Technologies Inc Earnings CallFebruary 15, 2024 | markets.businessinsider.comOptimistic Buy Rating for Palatin Technologies Backed by Strong Clinical Pipeline and Strategic InitiativesFebruary 15, 2024 | finanznachrichten.dePalatin Technologies, Inc.: Palatin Reports Second Quarter Fiscal Year 2024 Financial Results and Provides Corporate UpdateFebruary 15, 2024 | finance.yahoo.comPalatin Reports Second Quarter Fiscal Year 2024 Financial Results and Provides Corporate UpdateFebruary 15, 2024 | investorplace.comThe 3 Best Penny Stocks to Buy in February 2024February 15, 2024 | prnewswire.comPalatin Reports Second Quarter Fiscal Year 2024 Financial Results and Provides Corporate UpdateFebruary 14, 2024 | marketbeat.comPalatin Technologies, Inc. (NYSEAMERICAN:PTN) Short Interest UpdatePalatin Technologies, Inc. (NYSEAMERICAN:PTN - Get Free Report) was the recipient of a significant drop in short interest in January. As of January 31st, there was short interest totalling 469,100 shares, a drop of 16.5% from the January 15th total of 561,600 shares. Based on an average daily volume of 326,000 shares, the days-to-cover ratio is presently 1.4 days. Approximately 3.1% of the company's stock are sold short.February 14, 2024 | marketbeat.comPalatin Technologies (NYSEAMERICAN:PTN) Share Price Passes Above Two Hundred Day Moving Average of $0.00Palatin Technologies (NYSEAMERICAN:PTN) Stock Price Passes Above 200-Day Moving Average of $0.00February 9, 2024 | finance.yahoo.comPalatin to Report Second Quarter Fiscal Year 2024 Results; Teleconference and Webcast to be held on February 15, 2024 Get Palatin Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for PTN and its competitors with MarketBeat's FREE daily newsletter. Email Address Trump’s Gift Could Unleash $51 Billion in New Wealth (Ad)In January 2021, Donald Trump silently rolled out a special gift to the American public… One that top house republicans called “The Key To America’s Economic Future”. You just have to make this simple move before July 30, 2024. PTN Media Mentions By Week PTN Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PTN News Sentiment▼0.000.76▲Average Medical News Sentiment PTN News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PTN Articles This Week▼12▲PTN Articles Average Week Get Palatin Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for PTN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: AMLX News KPTI News ADAG News IMUX News COYA News CLRB News ALLK News DMAC News PDSB News CLSD News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSEAMERICAN:PTN) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersBuy this small stock before coming AI Tidal WaveChaikin AnalyticsTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden replacement revealed?Paradigm PressWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsElon to Transform U.S. Economy? Porter & CompanyShocking $16T Elon Musk Crypto LeakCrypto 101 Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Palatin Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
